Tandem Diabetes Care Inc
TNDM
Market Cap$1.43B
Close$
$-5.17
122.7% downside
Current Fair Value
122.7% downsideOvervalued by 122.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.43 Billion |
|---|---|
| Enterprise Value | $1.74 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.47 |
| Beta | 1.53 |
| Outstanding Shares | 66,404,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.76 |
|---|---|
| PEG | 26.33 |
| Price to Sales | 1.42 |
| Price to Book Ratio | 11.37 |
| Enterprise Value to Revenue | 1.6 |
| Enterprise Value to EBIT | -13.5 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 2.32 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Tandem Diabetes Care Inc
1,600 employees
CEO: John Sheridan Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach t...